Sanjivani Paranteral Ltd. (SANJIVIN) Share Price Rises 13.65% Today
- July 28, 2026
- Posted by: Harsh Piplani
- Category: News
Sanjivani Paranteral Ltd. Share Price rises 13.65% today, reaching Rs 170.7 with a market cap of Rs 182.61 Cr.
Sanjivani Paranteral Ltd. Share Price experienced a significant rise today, closing at Rs 170.7, marking a 13.65% increase from the previous close of Rs 150.2. This substantial gain positions the company within the Micro Cap category, with a market capitalisation of Rs 182.61 crore. Despite the absence of a specific catalyst in the supplied data, the rise in share price may attract attention from market participants looking for opportunities in the Healthcare sector, particularly within the Pharmaceuticals & Drugs industry.
Sanjivani Paranteral Ltd. (SANJIVIN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 170.7 |
| Previous Close | Rs 150.2 |
| Today's Change | +Rs 20.5 (+13.65%) |
| Day Open | Rs 150 |
| Day High | Rs 174.95 |
| Day Low | Rs 150 |
| Current Volume (BSE) | 48,520 |
| BSE Traded Volume | 48,520 |
| Combined NSE + BSE Volume | 48,520 |
| Turnover | Rs 0.83 crore |
| Market Capitalisation | Rs 182.61 crore |
| Market Cap Category | Micro Cap |
Sanjivani Paranteral Ltd. (SANJIVIN) traded at Rs 170.7. versus the previous close of Rs 150.2, a rise of 13.65%. The stock opened at Rs 150, reached Rs 174.95, touched Rs 150. Reported volume was 48,520.
Sanjivani Paranteral Ltd. (SANJIVIN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 182.61 crore |
| P/E Ratio | 27.19x |
| P/B Ratio | 3.82x |
| ROE | 0% |
| ROCE | 266.43% |
| EPS | Rs 5.52 |
| Dividend Yield | 0% |
Sanjivani Paranteral Ltd. was valued at a P/E ratio of 27.19x, a P/B ratio of 3.82x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 0% and ROCE of 266.43%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 5.52, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 27.19x |
| Benchmark Median P/E | 26.62x |
| Benchmark Average P/E | 78.1x |
| Benchmark P/E Range | 3.65x to 3,482.29x |
| Company P/B Ratio | 3.82x |
| Benchmark Median P/B | 1.84x |
| Company ROE | 0% |
| Benchmark Median ROE | 9.93% |
| Company ROCE | 266.43% |
| Benchmark Median ROCE | 12.97% |
| Company Market Capitalisation | Rs 182.61 crore |
| Benchmark Median Market Cap | Rs 151.5 crore |
Sanjivani Paranteral Ltd. (SANJIVIN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs. The numerical benchmark uses 138 same industry companies from the supplied master-data set.
Sanjivani Paranteral Ltd. (SANJIVIN) has a P/E ratio of 27.19x, which is above the benchmark median of 26.62x, a difference of +2.14%. The benchmark contains 103 companies with P/E data, ranging from 3.65x to 3,482.29x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sanjivani Paranteral Ltd. (SANJIVIN) has a ROE of 0%, which is below the benchmark median of 9.93%, a difference of -100%. Sanjivani Paranteral Ltd. (SANJIVIN) has a ROCE of 266.43%, which is above the benchmark median of 12.97%, a difference of +1,954.2%.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Morepen Laboratories Ltd. | MOREPENLAB | 2,947.44 | 32.68 | 2.49 | 29.2 | 27.13 |
| Dishman Carbogen Amcis Ltd. | DCAL | 2,885.59 | 29.98 | 0.44 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,881.37 | 41.8 | 8.51 | 28.21 | 26.35 |
| Panacea Biotec Ltd. | PANACEABIO | 2,699.01 | 0 | 3.18 | 0 | 5.36 |
| Hikal Ltd. | HIKAL | 2,678.09 | 0 | 2.28 | 15.22 | 16.15 |
Sanjivani Paranteral Ltd. (SANJIVIN) has a P/E ratio of 27.19x compared with the displayed peer median of 29.98x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 0% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 266.43% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Sanjivani Paranteral Ltd. (SANJIVIN) has a market capitalisation of Rs 182.61 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Sanjivani Paranteral Ltd.
Investors are closely monitoring Sanjivani Paranteral Ltd. due to its recent price action and market positioning.
- Price Action: The share price rose by 13.65% today, indicating strong market interest.
- Technical Position: The RSI is at 48.98, suggesting neutral momentum.
- Fundamental Context: High ROCE of 266.43 indicates efficient capital use.
- Sector Positioning: Positioned competitively within the Pharmaceuticals & Drugs industry.
Investors should continue to monitor the company’s financial performance and market trends to assess future opportunities.
About Sanjivani Paranteral Ltd.
Sanjivani Paranteral Ltd. is a player in the Pharmaceuticals & Drugs industry, operating within the broader Healthcare sector. The company focuses on manufacturing and distributing pharmaceutical products, catering to various healthcare needs. Its business model revolves around producing high-quality drugs that meet industry standards. Despite its smaller market capitalisation, the company has demonstrated strong capital efficiency, as evidenced by its high ROCE. Sanjivani Paranteral Ltd. aims to leverage its industry expertise to expand its market presence and enhance shareholder value.
Track Sanjivani Paranteral Ltd. Share Price on Univest
Use Sanjivani Paranteral Ltd. (SANJIVIN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Investors can track Sanjivani Paranteral Ltd. Share Price on Univest to stay updated with live price movements, technical indicators, and fundamental ratios. Univest provides insights into the company’s shareholding pattern, 52-week levels, and market trends, helping investors make informed decisions. Stay connected with Univest for comprehensive market analysis and updates.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
How much did Sanjivani Paranteral Ltd. share price rise today?
Ans. The share price of Sanjivani Paranteral Ltd. rose by 13.65% today, closing at Rs 170.7, up from the previous close of Rs 150.2. The stock moved 13.65% during the session.
What is the market capitalisation of Sanjivani Paranteral Ltd.?
Ans. Sanjivani Paranteral Ltd. has a market capitalisation of Rs 182.61 crore, categorising it as a Micro Cap company. The company operates in the Healthcare sector. Its P/E ratio is 27.19x.
What is the P/E ratio of Sanjivani Paranteral Ltd.?
Ans. The P/E ratio of Sanjivani Paranteral Ltd. is 27.19, which is slightly above the industry median of 26.62. The company trades at a P/E ratio of 27.19x. Its P/B ratio is 3.82x.
How does Sanjivani Paranteral Ltd.'s ROCE compare to its peers?
Ans. Sanjivani Paranteral Ltd.'s ROCE of 266.43 is significantly higher than its peers, indicating superior capital efficiency. ROE stands at 0%. ROCE stands at 266.43%. The relevant peer median ROE is 9.93%.
What sector does Sanjivani Paranteral Ltd. operate in?
Ans. Sanjivani Paranteral Ltd. operates in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs. 138 comparable companies were included in the benchmark.
How does Sanjivani Paranteral Ltd.'s P/B ratio compare to the industry?
Ans. Sanjivani Paranteral Ltd.'s P/B ratio of 3.82 is higher than the industry median of 1.84, suggesting a premium valuation. The company trades at a P/E ratio of 27.19x. Its P/B ratio is 3.82x.
